Clinical Trial Results: A Study to Investigate the Safety and Efficacy of KER-012 in Combination With Background Therapy in Adult Participants With Pulmonary Arterial Hypertension (PAH) (TROPOS Study). [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating KER-012 in combination with background therapy for adult pulmonary arterial hypertension was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• KER-012

Snippet

Sponsor: Keros Therapeutics, Inc. | Conditions: Pulmonary Arterial Hypertension | Phase 2 | Status: TERMINATED | Results posted: 2026-07-02